Description

As an industrial pioneer in antibody-drug conjugate (ADC) development, Creative Biolabs offers customarily tailored ADC preparations with a variety of DNA-targeting toxins as payloads, including calicheamicins, doxorubicin, duocarmycin analogs, PBD-dimers, topotecan, bleomycin A2, dactinomycin, and mitomycin C.